(Q28188691)

1

0 references

R Klein

2

0 references

K E Lee

3

0 references

L G Danforth

The validity of self-reported and surrogate-reported cataract and age-related macular degeneration in the Beaver Dam Eye Study.

4

0 references

language of work or name

English

0 references

publication date

September 2001

0 references

published in

Ophthalmology

0 references

volume

108

0 references

issue

9

0 references

page(s)

1670-4

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900656-X

7 January 2021

The Beaver Dam Eye Study: visual acuity

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900656-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900656-X

7 January 2021

Prevalence of age-related maculopathy. The Beaver Dam Eye Study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900656-X

7 January 2021

The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900656-X

7 January 2021

Changes in visual acuity in a population. The Beaver Dam Eye Study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900656-X

7 January 2021

Assessment of cataracts from photographs in the Beaver Dam Eye Study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900656-X

7 January 2021

Prevalence of age-related lens opacities in a population. The Beaver Dam Eye Study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900656-X

7 January 2021

Longitudinal data analysis for discrete and continuous outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900656-X

7 January 2021

Medications and cataract. The Blue Mountains Eye Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900656-X

7 January 2021

The epidemiology of cataract in Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900656-X

7 January 2021

Ultraviolet light exposure and lens opacities: the Beaver Dam Eye Study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900656-X

7 January 2021

Hypertension and lens opacities from the Beaver Dam Eye Study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900656-X

7 January 2021

Diabetes, cardiovascular disease, selected cardiovascular disease risk factors, and the 5-year incidence of age-related cataract and progression of lens opacities: the Beaver Dam Eye Study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900656-X

7 January 2021

Do aspirin-like analgesics protect against cataract? A case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900656-X

7 January 2021

Protection against cataract by aspirin, paracetamol and ibuprofen

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900656-X

7 January 2021

Low-dose aspirin and risks of cataract in a randomized trial of US physicians

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900656-X

7 January 2021

Aspirin and cataracts

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900656-X

7 January 2021

Is aspirin use associated with lower rates of cataracts in diabetic individuals?

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900656-X

7 January 2021

A prospective study of aspirin use and cataract extraction in women

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900656-X

7 January 2021

No adjustments are needed for multiple comparisons

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900656-X

7 January 2021

The evolving case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900656-X

7 January 2021